Trial Profile
A randomised, double blind, placebo controlled, parallel group, 14 day repeat dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of inhaled GW685698X containing magnesium stearate in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Jun 2023
Price :
$35
*
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Asthma; Perennial allergic rhinitis; Seasonal allergic rhinitis
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 15 Oct 2008 Actual initiation date changed from 1 Mar 2007 to 1 Feb 2007 as reported by ClinicalTrials.gov.
- 24 Mar 2008 New trial record.